Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Pathology: Research and Practice

Volume  8, Issue 6, November-December 2019, Pages 725-732
 

Original Article

Immunocytochemical typing of Malignant Cells in Effusion: A Comparative Study with Routine Cytology in Central India

Anand Bhadkariya1, Vijay Kumar Chaudhary2, Dimple Arya3, Arjun Singh4

1Associate Professor 2Assistant Professor 4Professor and Head, Department of Pathology, 3Senior Resident, Department of Anesthesia, Government Medical College, Datia, Madhya Pradesh 475661, India.

Choose an option to locate / access this Article:
60 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.8619.2

Abstract

Introduction: Effusion of serous cavities is commonly encountered in clinical practice. If we know the primary site, it is possible to avoid the unnecessary exploratory surgery. Diagnostic paracentesis should be a part of the routine evaluation of the patient with effusion. In many cases, a definitive diagnosis cannot be reached based on morphology alone; thus, the diagnostic yield and its accuracy in effusion cytology can be enhanced though the utilization of ancillary techniques. Many previous studies have shown the role of immunocytochemical (ICC) in diagnosis in malignant cells. Material and Method: 55 cases of serous effusions were included in this study. Routine examination of specimen was done after proper patient identifications. For Immunocytochemistry Polymeric technique was performed on cell smear preparation, prepared earlier. Results: in the present study cytological evaluation along with immunocytochemical analysis of 55 cases, presenting with serous effusion was done. The patients were of the age range from 19 to 77 years. We studied 55 effusion fluids in which 23 (41.81%) effusions were found to be of inflammatory etiology because of predominance of inflammatory cells and reactive mesothelial cells in them, followed by 21 (38.18%) fluids showing malignant metastatic deposits. All prepared smears were then subjected for immunocytochemical staining utilizing antibody for CEA, and cytokeratin. Positive immunostaining for CEA was obtained in 11 out of 21 cytological malignant effusions. All the epithelial origin tumors including squamous cell carcinoma and mesothelioma are positive for cytokeratin. Adenocarcinoma are negative for cytokeratin Unequivocal cytoplasmic staining observed in >20–30% tumor cells was considered positive. Positive immunostaining for cytokeratin was obtained in three cases out of 21 cytologically malignant effusions. Cytokeratin was consistently absent in all the cytologically benign effusions. Discussion: ICC is an established important adjunct diagnostic tool for differentiate among various tumors. This study was designed to study the immunocytochemical reactivity patterns of various antibodies with cells of malignant and benign effusions and to evaluate their potential role in routine diagnostic cytology. Conclusions: CEA was found to be 64.28% sensitive in cytologically positive cases of adenocarcinoma similarly Cytokeratin has 75% sensitivity as a tumor marker in cytologically positive cases of squamous cell carcinoma.

Keywords: Immunocytochemistry; Effusion; CEA; Cytokeratin; Malignancy; Adenocarcinoma; Squamous cell carcinoma.


Corresponding Author : Vijay Kumar Chaudhary